Skip to main content
Nina Resetkova, MD, MBA

Nina Resetkova, MD, MBA

Reproductive Endocrinologist Fellow of the American College of Obstetricians and Gynecologists (FACOG) MD/MBA, Health Organization Management

Why Choose

01

Double board-certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility

02

Combined M.D. and M.B.A., specializing in health organization management

03

Co-author of the 2019 Fertility and Sterility study comparing ART outcomes in female-to-male transgender and cisgender patients

04

Co-author of a Human Reproduction framework for counselling patients on whether to test embryos with PGT-A

05

Cost-effectiveness research on preimplantation genetic screening selected for a prize oral presentation at the 2013 ASRM annual meeting

06

RNA sequencing work on human embryo competence published in Genome Research with Harvard stem cell biologists

07

Fellow of the American College of Obstetricians and Gynecologists; served in an executive role at the New England Fertility Society

08

Research fellowship in the Harvard Department of Stem Cell and Reproductive Biology

09

In-person consults at the Downtown Boston fertility center; telehealth in Massachusetts and Rhode Island

About

About

Cost-effectiveness analysis is an odd preoccupation for a fertility doctor, and Dr. Nina Resetkova holds the two degrees that make it a formal one: she earned an M.D. and an M.B.A. together at Texas Tech University Health Sciences Center, the business degree specializing in health organization management. Her research applies that training to the questions patients are asked to decide without data: whether preimplantation genetic screening is worth its price for people with recurrent pregnancy loss — work selected for a prize oral presentation at the 2013 ASRM annual meeting — and, in a 2019 Human Reproduction paper, a practical framework for counselling patients on whether to test embryos at all. She also completed a research fellowship in the Harvard Department of Stem Cell and Reproductive Biology, using RNA sequencing to ask whether embryo gene expression predicts competence, published in Genome Research.

The other published strand in her work is family building for LGBTQ patients. The 2019 Fertility and Sterility paper comparing assisted reproduction outcomes between female-to-male transgender patients and cisgender patients carried two Boston IVF names in its author line, and one of them was hers; she co-authored it with Dr. Kim Thornton and the network’s embryology team, then followed it with a F S Reports commentary arguing that lesbian women’s path to pregnancy deserves a written best-practice standard of its own. For Resetkova this is not a referral category; it is published territory.

Born in Slovakia and raised in Toronto from a young age, she took a biochemistry degree with a management minor at McGill University before the combined M.D./M.B.A. at Texas Tech and a competitive OB/GYN residency at Johns Hopkins Hospital in Baltimore, where she served on the ethics and quality improvement committees and was elected Vice Chair of Communications on the House Staff Council. She is double board-certified in OB/GYN and REI and a Fellow of the American College of Obstetricians and Gynecologists, has held an executive role in the New England Fertility Society, and consults in person at Boston IVF’s Downtown Boston center, with telehealth across Massachusetts and Rhode Island. Her profile is carried on this Waltham page because the two centers are one network; the consult site published for her is downtown, and patients booking through Waltham should expect to be scheduled there or by telehealth.

Clinical Expertise

  • LGBTQ+ family building: Reciprocal IVF, donor sperm, co-parenting arrangements and the counselling framework she helped propose in print
  • Transgender fertility preservation: A co-author of the first comparative outcome study in this population
  • PGT-A decision-making: Not whether testing is possible, but whether it pays off for a given patient — the subject of her award-selected cost-effectiveness research
  • Recurrent pregnancy loss: Including genetic screening questions in the loss context
  • Fertility preservation and exploration: Egg, embryo and sperm freezing for patients delaying or investigating
  • IVF and ICSI: Cycle management with attention to obstetric outcomes after assisted conception
  • Pregnancy complications after IVF: Her recent papers cover ischemic placental disease risk after donor oocytes and frozen transfer, and early beta-hCG as a marker

Why Choose Dr. Nina Resetkova

She has published the cost of the test you are being sold. Patients are rarely told whether PGT-A is worth its price for their specific situation; her prize-presented health-economics work and her Human Reproduction counselling framework are exactly that question.

An MBA inside the clinic. Health organization management training explains her interest in workflow and quality — and, for a patient, tends to show up as fewer loose ends between monitoring, retrieval and transfer.

She co-authored the transgender outcomes study. Fertility preservation counselling for a transgender patient usually runs on assumption; she has the primary data behind her advice.

Ethics committee training at Johns Hopkins. Residency years spent on ethics and quality improvement, plus elected house-staff leadership, in one of the country’s most competitive programs.

Two languages and three health systems. Slovak and English, with Canadian education, US residency and a Harvard research fellowship — relevant for international and immigrant families.

Professional Affiliations

Fellow of the American College of Obstetricians and Gynecologists; American Society for Reproductive Medicine; New England Fertility Society, where she served in an executive role. Double board-certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility.

Suitable For

  • Lesbian couples planning reciprocal IVF: She has argued in print that this path needs a best-practice standard, and practises it
  • Transgender patients freezing gametes: Counselling grounded in the comparative outcome study she co-authored
  • Couples weighing whether to do PGT-A: The cost-effectiveness question is her published specialty, not a brochure decision
  • Repeated miscarriage patients: Genetic screening and loss management are named research interests
  • Rhode Island and Boston-area patients: In-person care downtown, telehealth in both states

Best For

Lesbian couples, transgender patients and single parents building families Transgender patients considering egg freezing before transition Couples deciding whether PGT-A is worth the cost in their case Recurrent pregnancy loss and follow-up after an IVF pregnancy Rhode Island patients who want Boston-area care without travelling far

Specialties

In Vitro Fertilization (IVF)
ICSI (Intracytoplasmic Sperm Injection)
LGBTQ+ Family Building
Fertility Preservation
PGT-A (Embryo Genetic Screening)
Recurrent Pregnancy Loss

Education

Research fellowship: Harvard Department of Stem Cell and Reproductive Biology - RNA profiling of the developing embryo
Residency: Obstetrics and Gynecology, Johns Hopkins Hospital, Baltimore
M.B.A.: Texas Tech University - Health Organization Management
M.D.: Texas Tech University Health Sciences Center School of Medicine
Biochemistry, B.Sc. with a minor in Management: McGill University

Languages

en
sk

Career Timeline

PresentReproductive endocrinologist at Boston IVF, consulting at the Downtown Boston fertility center
2019Co-authored the Fertility and Sterility comparison of ART outcomes in transgender and cisgender patients
2013Cost-effectiveness study of preimplantation genetic screening chosen for a prize oral presentation at the ASRM annual conference
TrainingResearch fellowship in the Harvard Department of Stem Cell and Reproductive Biology; OB/GYN residency at Johns Hopkins Hospital

Ready to book Dr. Nina Resetkova, MD, MBA?

Our medical advisors will arrange a consultation time with the doctor for you